ENALAPRIL FOR POSTTRANSPLANT ERYTHROCYTOSIS

依那普利治疗移植后红细胞增多症

• 批准号: 3738986
• 负责人: ROBERT S GASTON
• 金额: --
• 依托单位: UNIVERSITY OF ALABAMA AT BIRMINGHAM
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/3738986
• 关键词: blood disorder; blood disorder chemotherapy; drug screening /evaluation; enalapril; erythrocyte count; erythropoiesis; human subject; human therapy evaluation; kidney transplantation; postoperative complications

A study designed to evaluate the efficacy and mechanism of enalapril (Vasotec) in the treatment of posttreatment erythrocytosis a complication which may predispose kidney transplant recipients to increased risk of blood clots.

依那普利的疗效及作用机制研究 （Vasotec）治疗治疗后红细胞增多症（一种并发症） 这可能使肾移植受者的风险增加， 血块